03 February 2016

Global circulating tumor cells market is anticipated to reach USD 11,552.3 million by 2022, according to a new report by Grand View Research, Inc. Rising developments in the field of biomedical engineering and biomedical imaging coupled with rise in patented research initiatives by the government is expected to drive this industry through the forecast period.
Introduction of novel technologies for enumeration of circulating tumor cells is anticipated to fuel growth in this sector through to 2022. Furthermore, increasing incidences of chronic oncology diseases that depend on the detection and analysis of CTCs, as it has enormous potential in the real-time monitoring of cancer therapy, over the conventional methods such as imaging technologies and tumor tissue biopsy.

Click For Full TOC Details And Sample Report Of This Report @ http://www.grandviewresearch.com/industry-analysis/circulating-tumor-cells-market

Further key findings from the study suggest:
• CTC enrichment accounted for the largest share of market revenue in 2014 and is expected to continue this dominance owing to high usage rates in oncology research establishments and high accuracy exhibited by this technology.
• Microchips technology is anticipated to register substantial growth in the next seven years because of the introduction of cluster chip technology that enables capture of clusters of tumor cells for CTC quantitation.
• Characteristic property of the cancer stem cells of self-renewal in replenishing the growing cancer is driving the attention of organizations and researchers in CTC cancer stem cell research segment thus accounting for the segment’s large share in revenue generation.
• Application of alterations witnessed in the expression profiles of EMT-associated transcriptional regulators and their molecular targets as biomarkers in EMT study is expected to serve as an impetus for diagnosis of tumour recurrence consequently driving the segment with a double digit CAGR of over 10%.

Request for free sample of this Report @ http://www.grandviewresearch.com/industry-analysis/circulating-tumor-cells-market/request

Grand View Research has segmented circulating tumor cells market on the basis of technology, application, and region:
Global Circulating Tumor Cell Technology Outlook (Revenue, USD Million, 2012 – 2022)
• CTC Enrichment
• CTC Detection
• CTC Analysis
Circulating Tumor Cell Regional Outlook (Revenue, USD Million, 2012 – 2022)
• North America
• Europe
• Asia Pacific
• Latin America

Access More Details About Category Of This Report @ http://www.grandviewresearch.com/industry/biotechnology

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research

Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Blog Site: http://www.mediafound.org/

  • 4k
  • 5
    Avg Daily Vews
  • 1 Day
  • 1 Week
  • 1 Month
  • 2 Months
  • 6 Months
  • 1 Year